Bridging stent placement through the superior vena cava to the inferior vena cava in a patient with malignant superior vena cava syndrome and an iodinated contrast material allergy

Background. In the superior vena cava syndrome, vein catheterisation provides an alternative for vascular access. Few reports describe the usage of femoral ports.Aim. Description of pros and contras for femoral port installation in patients with haematological malignancies and the superior vena cava syndrome.Materials and methods. This prospective non-randomised, single-centre study included 163 haematological patients implanted 72 ports in superior vena cava, 35 — in inferior vena cava and inserted with 156 non-tunnelled femoral catheters. Catheterisation properties, complications, duration of use and reasons for port and catheter removal were registered.Results. No signiﬁcant differences were observed between ports in superior and inferior vena cava as per the frequency of urokinase use in catheter dysfunction, catheter dislocation, catheter-associated bloodstream and pocket infections. Differences were revealed in the catheter-associated thrombosis rate, which was higher with femoral access (17.0 % or 0.9/1000 catheter days vs. 8.3 % or 0.2/1000 catheter days, p = 0.017). Ports in inferior vena cava had a lesser duration of use than in superior vena cava (p = 0.0001). Unlike femoral ports, non-tunnelled femoral catheters had higher rates of catheter-associated thrombosis (9/1000 vs. 0.9/1000 catheter days, p = 0.002) and infection (4.9/1000 vs. 0.3/1000 catheter days, p = 0.002). One lymphoma therapy course required one femoral port or 1 to 14 (median 3) non-tunnelled femoral catheters.Conclusion. Femoral port implantation is a necessary measure in patients with the superior vena cava syndrome. It has advantages in terms of catheterisation frequency, lower infectious and thrombotic complication rates compared to non-tunnelled femoral catheters.

Download Full-text

Preferential Visualization of the Inferior Vena Cava in the Dynamic Hepatic Flow Study of the Superior Vena Cava Syndrome

Clinical Nuclear Medicine ◽

10.1097/00003072-197709000-00002 ◽

1977 ◽

Vol 2 (9) ◽

pp. 296-297

Author(s):

HEE KYUNG LEE

Keyword(s):

Inferior Vena Cava ◽

Superior Vena Cava ◽

Inferior Vena ◽

Superior Vena Cava Syndrome ◽

Superior Vena ◽

Vena Cava ◽

Vena Cava Syndrome ◽

Flow Study

Download Full-text

Acute superior vena cava syndrome resulting from inferior vena cava cross-clamping

Journal of Cardiothoracic and Vascular Anesthesia ◽

10.1016/s1053-0770(97)90215-9 ◽

1997 ◽

Vol 11 (2) ◽

pp. 197-200 ◽

Cited By ~ 5

Author(s):

Robert J. Suriani ◽

Mark Abel

Keyword(s):

Inferior Vena Cava ◽

Superior Vena Cava ◽

Inferior Vena ◽

Superior Vena Cava Syndrome ◽

Superior Vena ◽

Vena Cava ◽

Vena Cava Syndrome

Download Full-text

Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond

Seminars in Interventional Radiology ◽

10.1055/s-0037-1608863 ◽

2017 ◽

Vol 34 (04) ◽

pp. 398-408 ◽

Cited By ~ 15

Author(s):

Tamir Friedman ◽

Keith Quencer ◽

Sirish Kishore ◽

Ronald Winokur ◽

David Madoff

Keyword(s):

Inferior Vena Cava ◽

Superior Vena Cava ◽

Inferior Vena ◽

Superior Vena Cava Syndrome ◽

Superior Vena ◽

Vena Cava ◽

Endovascular Management ◽

Venous Obstruction ◽

Central Venous ◽

Vena Cava Syndrome

AbstractVenous obstruction in the cancer population can result in substantial morbidity and, in extreme cases, mortality. While venous obstruction can be caused by both benign and malignant etiologies in this population, the management of malignant venous obstruction as a palliative measure can be somewhat nuanced with respect to nonprocedural and procedural management, both with respect to treatment of the underlying malignancy as well as treatment of venous hypertension, which may be associated with venous thrombosis. Symptom severity, primary malignancy, functional status, and prognosis are all fundamental to the patient workup and dictate both the timing and extent of endovascular intervention. The morbidity and mortality associated with malignant obstructions of central venous structures, specifically the superior vena cava and inferior vena cava, can be significantly improved with endovascular management in appropriately selected patients. Thus, the pertinent literature regarding the clinical presentation, workup, and endovascular management of malignant central venous obstruction syndromes, with directed attention to superior vena cava syndrome and inferior vena cava syndrome, will be reviewed in this article.

Download Full-text